Valortim in Medical Technology
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
Pilot Study Demonstrates 50% Survival in Valortim-Treated Animals
PRINCETON, N.J. and ANNAPOLIS, Md., March 29, 2007
/PRNewswire-FirstCall/ -- Medarex, Inc. , a leading monoclonal
antibody company, and PharmAthene, Inc., a privately held
biotechnology company dedicated to the development...
Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
... with Drs. Cross and Basu to better characterize these intriguing results.
valortim (R) has demonstrated efficacy in non-clinical studies as well as favorable safety data collected from our Phase I clinical study. We believe that
valortim (R) may have important competitive advantages, including a novel mechanism...
Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection
... the rapid assay, animals were
administered either
valortim or saline (control) by intravenous
injection. In t... in which to
determine the therapeutic efficacy of
valortim in animals confirmed
to have active disease. We be... rabbit animal model had suggested the
capacity of
valortim to successfully treat symptomatic animals,"
noted ...
Valortim in Biological Technology
PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
...ous Disease, National Institutes of Health.
valortim (R) PK Findings Reported
Pharmacokinetic da... challenge of the anthrax Ames strain.
About
valortim (R)
Valortim(R) is a fully human monoclonal a...oms become evident).
As previously presented,
valortim has been administered intravenously and intramuscu...
Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
...ection, further defining the potential efficacy
of
valortim in anthrax disease," commented Dr. Lowy. "Animal m..., supporting
the accuracy of the approach and that
valortim had impressive activity in
this setting. This stud... inhalation disease, and to assess
the efficacy of
valortim in this model. In the study, 32 adult NZW rabbits
...
PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
...uct development will help
to ensure the success of
valortim (TM) and Protexia(R), our biodefense
product candi...ents, respectively."
Mr. Wright continued, "Both
valortim and Protexia continue to make
excellent progress. ...00L engineering run. If successful, it
will enable
valortim to be positioned for procurement by the U.S.
gover...